These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32914327)
1. Intestinal occlusion by gynecological cancers treated by percutaneous endoscopic gastrostomy and lanreotide: an Aviano National Cancer Institute experience. Budel M; Martella L; Zambon L; Morson I; Giorda G; Cannizzaro R Support Care Cancer; 2021 Feb; 29(2):547-549. PubMed ID: 32914327 [TBL] [Abstract][Full Text] [Related]
2. Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study. Mariani P; Blumberg J; Landau A; Lebrun-Jezekova D; Botton E; Beatrix O; Mayeur D; Herve R; Maisonobe P; Chauvenet L J Clin Oncol; 2012 Dec; 30(35):4337-43. PubMed ID: 23109694 [TBL] [Abstract][Full Text] [Related]
3. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Campagnutta E; Cannizzaro R; Gallo A; Zarrelli A; Valentini M; De Cicco M; Scarabelli C Gynecol Oncol; 1996 Jul; 62(1):103-5. PubMed ID: 8690280 [TBL] [Abstract][Full Text] [Related]
4. Palliative interventions in patients with peritoneal metastases and malignant bowel obstruction. Bellavance EC; Alexander HR J Clin Oncol; 2012 Dec; 30(35):4290-1. PubMed ID: 23109693 [No Abstract] [Full Text] [Related]
5. Somatostatin analogs for malignant bowel obstruction resulting from peritoneal carcinomatosis. Zelek L; Laval G; Asselain B J Clin Oncol; 2013 Jul; 31(19):2519-20. PubMed ID: 23733778 [No Abstract] [Full Text] [Related]
6. Percutaneous endoscopic gastrostomy (PEG) in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer: a review. Campagnutta E; Cannizzaro R Eur J Gynaecol Oncol; 2000; 21(4):397-402. PubMed ID: 11055494 [TBL] [Abstract][Full Text] [Related]
7. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Diver E; O'Connor O; Garrett L; Boruta D; Goodman A; Del Carmen M; Schorge J; Mueller P; Growdon W Gynecol Oncol; 2013 May; 129(2):332-5. PubMed ID: 23402902 [TBL] [Abstract][Full Text] [Related]
8. Decompressive percutaneous gastrostomy tube use in gynecologic malignancies. Meyer L; Pothuri B Curr Treat Options Oncol; 2006 Mar; 7(2):111-20. PubMed ID: 16455022 [TBL] [Abstract][Full Text] [Related]
9. Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study. Zucchi E; Fornasarig M; Martella L; Maiero S; Lucia E; Borsatti E; Balestreri L; Giorda G; Annunziata MA; Cannizzaro R Support Care Cancer; 2016 Jul; 24(7):2877-82. PubMed ID: 26838026 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217 [TBL] [Abstract][Full Text] [Related]
11. Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention. Perri T; Korach J; Ben-Baruch G; Jakobson-Setton A; Ben-David Hogen L; Kalfon S; Beiner M; Helpman L; Rosin D Eur J Surg Oncol; 2014 Jul; 40(7):899-904. PubMed ID: 24268761 [TBL] [Abstract][Full Text] [Related]
12. Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Malone JM; Koonce T; Larson DM; Freedman RS; Carrasco CH; Saul PB Obstet Gynecol; 1986 Sep; 68(3):431-3. PubMed ID: 2426641 [TBL] [Abstract][Full Text] [Related]